Legend Biotech (LEGN) Revenue (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.47% |
| Sep 30, 2025 | 6.77% |
| Jun 30, 2025 | 30.76% |
| Mar 31, 2025 | 4.59% |
| Dec 31, 2024 | 16.41% |
| Sep 30, 2024 | -14.11% |
| Jun 30, 2024 | 98.45% |
| Mar 31, 2024 | -99.88% |
| Dec 31, 2023 | 82,663.79% |
| Sep 30, 2023 | 30.93% |
| Jun 30, 2023 | 101.81% |
| Mar 31, 2023 | 31.49% |
| Dec 31, 2022 | 0.99% |
| Sep 30, 2022 | 128.56% |
| Jun 30, 2022 | -76.08% |
| Mar 31, 2022 | 28.32% |
| Dec 31, 2021 | 130.99% |
| Sep 30, 2021 | -16.56% |
| Jun 30, 2021 | 47.88% |
| Mar 31, 2021 | -66.45% |
| Dec 31, 2020 | 247.18% |
| Sep 30, 2020 | 1.27% |
| Jun 30, 2020 | 0.47% |
| Mar 31, 2020 | -40.64% |
| Dec 31, 2019 | 10.05% |
| Sep 30, 2019 | 75.22% |